2019 Webinar: Integrated Management of Alcohol-Related Liver Disease with Hepatologists and Addiction Specialists

0 (1 vote)

Recorded On: 10/24/2019

Patients with ALD and alcohol-related acute hepatitis (AH) have two diseases of liver failure with complications and of alcoholism or alcohol use disorder (AUD). Clearly, these patients need at least two or may be more specialists as basis for integrated and effective management and improved outcomes of this disorder. We will utilize a live webinar format that will be recorded for on-demand viewing on LiverLearning®.

Ashwani K. Singal

Dr. Singal is an Associate Professor of Medicine at the University of South Dakota Sanford School of Medicine and Transplant Hepatologist at the Avera Transplant Institute. In addition, he also directs the hepatology elective course for the senior medical students at the Sanford Medical School and is Chief of Clinical Research Affairs at the Avera Transplant Institute. With clinical and translational research interests in alcoholic and non-alcoholic fatty liver diseases, renal injury in cirrhosis, and porphyria, Dr. Singal’s research has been funded by the American College of Gastroenterology, National Institute of Health, and pharmaceutical industry.

He has over 160 original peer reviewed articles in national and international journals and book chapters. As an active executive member of the ACG practice parameters committee, Dr. Singal has developed practice guidelines for alcoholic liver disease and vascular disorders of the liver and currently involved in writing the guidelines on nutritional management of patients with cirrhosis. He also reviews research grants and scientific research abstracts for the AGA and AASLD. Dr. Singal is currently the Secretary and the Education subcommittee Chair of the Alcoholic Liver Disease Special Interest Group at AASLD.

Lorenzo Leggio

Lorenzo Leggio, MD, PhD, MSc is a physician-scientist who conducts clinical research on medication development and the role of neuroendocrine pathways in addictions. He is also an expert in the management and treatment of alcohol use disorder in patients with alcohol-related liver disease Dr. Leggio received his MD and PhD from the Catholic University of Rome and ‘Agostino Gemelli’ hospital (Italy), where he also completed residency and received Board Certification in Internal Medicine. He also received a masters in ‘Alcohol-related Diseases and Problems’ from the University of Florence. He was a visiting research associate, then postdoctoral research associate in Psychiatry and Human Behavior at Brown University in Providence, Rhode Island. Throughout his career, he has worked as a faculty member and principal investigator at Brown University and National Institutes of Health.

Geetanjali Chander (Moderator)

Geetanjali Chander, MD, MPH is an Associate Professor of Medicine and Epidemiology at Johns Hopkins University (JHU) School of Medicine. She is also an attending physician in the Bartlett Specialty Practice at Johns Hopkins Hospital where she practices HIV medicine among persons with alcohol, tobacco and other drug use. Her research focuses on the integration of evidence-based treatments for alcohol use into HIV, liver transplant and other clinical settings.

She is a co-investigator on a NIAAA funded P50 focused on liver transplant among persons with acute alcohol related liver disease. For over 15 years she has been a co-investigator with the Johns Hopkins HIV Clinical Cohort. She is currently the PI of a U34 planning grant that uses community-based participatory research (CBPR) to implement alcohol interventions for women with and at risk of HIV. She is also the multi-PI of the administrative core of the NIAAA Alcohol Research Consortium in HIV (ARCH), which supports both an intervention arm and an epidemiology arm within the CFAR Network of Integrated Clinical Systems (CNICS), a multisite clinical cohort of persons with HIV.

Dr. Chander is the Director of Research for the Brancati Center for the Advancement of Community Care at Johns Hopkins. The Brancati Center seeks to improve the health of communities by developing, evaluating and disseminating new models of healthcare that leverage the skills of a diverse range of health care providers.

Key:

Complete
Failed
Available
Locked
Integrated Management of Alcohol-Related Liver Disease with Hepatologists and Addiction Specialists
Open to view video.
Open to view video. Presenters: Lorenzo Leggio, MD, PhD, MSc and Ashwani K. Singal, MD, MS, FACG, FAASLD Moderator: Geetanjali Chander, MD, MPH
Final Evaluation
Final Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.